Cargando…
Mesenchymal Stem Cells for Severe Intraventricular Hemorrhage in Preterm Infants: Phase I Dose‐Escalation Clinical Trial
We previously demonstrated that transplanting mesenchymal stem cells (MSCs) improved recovery from brain injury induced by severe intraventricular hemorrhage (IVH) in newborn rats. To assess the safety and feasibility of MSCs in preterm infants with severe IVH, we performed a phase I dose‐escalation...
Autores principales: | Ahn, So Yoon, Chang, Yun Sil, Sung, Se In, Park, Won Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265626/ https://www.ncbi.nlm.nih.gov/pubmed/30133179 http://dx.doi.org/10.1002/sctm.17-0219 |
Ejemplares similares
-
Mesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage
por: Ahn, So Yoon, et al.
Publicado: (2014) -
Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial
por: Ahn, So Yoon, et al.
Publicado: (2021) -
Dexamethasone does not prevent hydrocephalus after severe intraventricular hemorrhage in newborn rats
por: Lee, Jang Hoon, et al.
Publicado: (2018) -
Optimal Route for Mesenchymal Stem Cells Transplantation after Severe Intraventricular Hemorrhage in Newborn Rats
por: Ahn, So Yoon, et al.
Publicado: (2015) -
Thrombin Preconditioning Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in Severe Intraventricular Hemorrhage Induced Neonatal Rats
por: Jung, So Yeon, et al.
Publicado: (2022)